Clinical Trials Browser

INDUSTRY × Thrombocytopenia × oprelvekin × Clear all

NCT01663441 2020-09-16

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Phase 3 Completed

Classical hematology

Thrombocytopenia